James D Berry MD

Neurology•Boston, MA

Neuromuscular Medicine

Instructor, Neurology, Massachusetts General Hospital, Harvard Medical School

Join to View Full Profile

55 Fruit St Fl 8Boston, MA 02114
Phone+1 617-724-3914

Education & Training

Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 2006 - 2009
Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 2005 - 2006
Northwestern University The Feinberg School of MedicineClass of 2005

Certifications & Licensure

MA State Medical License 2009 - 2025
American Board of Psychiatry and Neurology Neurology
American Board of Psychiatry and Neurology Neuromuscular Medicine

Clinical Trials

A Longitudinal Study of Amyotrophic Lateral Sclerosis (ALS) Biomarkers Start of enrollment: 2011 Nov 01
Completed
Gilenya in Amyotrophic Lateral Sclerosis (ALS) Start of enrollment: 2013 Aug 01
Completed
Phase 2
Longitudinal Study of Outcomes Measures in ALS Trials Start of enrollment: 2013 Jul 01
Completed
Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS) Start of enrollment: 2013 Aug 01
Completed
Phase 2
Phase 2, Randomized, Double Blind, Placebo Controlled Multicenter Study of Autologous MSC-NTF Cells in Patients With ALS Start of enrollment: 2014 May 01
Completed
Phase 2
Open Label Extension Study of AMX0035 in Patients With ALS Start of enrollment: 2018 Mar 29
Completed
Phase 2
T-regulatory Cells in ALS Start of enrollment: 2019 Aug 07
Active, not recruiting
Phase 2
RAPA-501 Therapy for ALS Start of enrollment: 2024 Dec 01
RECRUITING
PHASE2, PHASE3
A Phase 2a Study of TPN-101 in Patients With Progressive Supranuclear Palsy (PSP) Start of enrollment: 2021 Oct 15
Active, not recruiting
Phase 2
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

An Expanded Access Protocol of RNS60 in Amyotrophic Lateral Sclerosis.
Grace Addy, Erica Scirocco, Dario Gelevski, Margot Rohrer, Aimee Roderick
Muscle & Nerve. 2025-03-21
Single-cell transcriptomic and functional studies identify glial state changes and a role for inflammatory RIPK1 signaling in ALS pathogenesis.
Matija Zelic, Anna Blazier, Fabrizio Pontarelli, Michael LaMorte, Jeremy Huang
Immunity. 2025-03-18
Clinician Perspectives Highlight the Need for Early Dyadic Coping Skills for People Living With Amyotrophic Lateral Sclerosis.
Christina L Rush, Chris Lyons, Jenna Gittle, Morgan Seward, Jennifer Scalia
Journal of Pain and Symptom Management. 2025-03-01

Press Mentions

ALL ALS Consortium Creates a Central Information Hub to Accelerate ALS ResearchMarch 30th, 2025
Healey & AMG Center for ALS Launches ALS MyMatch: An Early Phase Biomarker Driven Trial ProgramFebruary 25th, 2025
Mitsubishi Tanabe Pharma America Announces Real-World Data Analysis of Disease Progression with RADICAVA® (Edaravone) in ALSJanuary 29th, 2025
Join now to see all

Grant Support

An Intermediate-Size Expanded Access Protocol for Amyotrophic Lateral Sclerosis with PridopidineMASSACHUSETTS GENERAL HOSPITAL2023–2027
A diagnostic biomarker for amyotrophic lateral sclerosisJOHNS HOPKINS UNIVERSITY2023–2027
Intermediate-Size Expanded Access Trial of Autologous Hybrid TREG/Th2 Cell Therapy (RAPA-501) of Amyotrophic Lateral SclerosisMASSACHUSETTS GENERAL HOSPITAL2023–2026
Intermediate-Size Expanded Access Trial of Autologous Hybrid TREG/Th2 Cell Therapy (RAPA-501) of Amyotrophic Lateral SclerosisMASSACHUSETTS GENERAL HOSPITAL2023–2026
Access for All in ALS (ALL ALS) East Clinical Coordinating CenterMASSACHUSETTS GENERAL HOSPITAL2023–2025
Access for All in ALS (ALL ALS) East Clinical Coordinating CenterMASSACHUSETTS GENERAL HOSPITAL2023–2025
An Expanded Access Protocol of Intravenous Trehalose Injection 90 mg/mL Treatment of Patients with Amyotrophic Lateral SclerosisMASSACHUSETTS GENERAL HOSPITAL2022–2025